Most Emerging DSOs Won't Be Bought by Private Equity.
What Sophisticated Buyers Are Actually Evaluating
Dental consolidation is far from over, but it has become selective. A few years ago the conversation centered on location count. Today buyers are underwriting something more nuanced, and the gap between good platforms and great ones is widening. Acquiring practices creates scale. Operating them well is what creates value, and that distinction is what shows up in your multiple.
Unit-level economics over location count. Same-store sales growth, provider retention, recruiting success, patient experience, and operational consistency are what get underwritten now.
Strategic fit often outweighs size. A joint venture platform with real doctor equity is most attractive to a buyer who already believes in doctor equity. A centralized holdco is a better fit for a buyer who operates that way. Your operating model shapes who your natural partner is.
Leverage discipline protects your options. Debt accelerates acquisitions, but too much of it narrows your choices when the right strategic opportunity arrives. Optimizing for the next acquisition instead of the next chapter is the most common mistake we see.
Organizational alignment makes you easier to buy. Standardized doctor agreements, uniform legal documentation, clear governance, and consistent incentive structures all reduce a buyer's integration risk.
Doctor alignment surfaces when it matters most. If your partner doctors do not share the long-term vision, that friction appears during diligence rather than before it.
Buyers want a business that thrives beyond any one person. Some acquirers retain existing leadership and some have no need for a second executive team. Knowing which you are talking to changes how you negotiate.
Your Journey, Three Phases
Every transition is unique, but the path follows a proven rhythm. Each phase is guided by our 7 Pillars Framework, ensuring no angle goes unexamined. We walk with you so you feel informed, supported, and in control.
- DISCOVER (Steps 1-3)
Understanding Your Goals
Guided by the 7 Pillars Framework, we start by defining success on your terms. We assess your financial value, personal objectives, and risk tolerance to build a clear picture before anything moves forward.
Define your goals and what an ideal transition looks like
Educate you on available options and the current market
Analyze unit-level economics, operations, and growth
- EXECUTION (Steps 4-6)
Finding the Right Partner
With your 7 Pillars assessment complete, we go to market strategically. We evaluate partner fit, quantitative alternatives, and transaction timing to identify buyers and negotiate terms that reflect the full value of what you have built.
Identify partners aligned with your operating model
Procure multiple offers and create apples-to-apples comparisons
Facilitate a well-structured Letter of Intent
- CLOSE (Steps 7-10)
Closing with Confidence
We stay by your side through due diligence, legal review, and closing. Every pillar of your deal is validated before you sign, and we continue supporting you as you transition into the next chapter of your career and life.
Navigate due diligence with full team support
Partner with your legal team to finalize all documents
Close the deal and guide your post-close transition
Our Proven 10-Step Process
From initial discovery to life after close, here is exactly how we guide you through every stage of your transition.
- DISCOVER (Steps 1-3)
- EXECUTION (Steps 4-6)
- CLOSE (Steps 7-10)
Goal Discovery Discovery
We align on how we define success, understand your goals, and identify what an ideal transition looks like for you.
Education Discovery
We educate you on the process and explore your available options, ensuring the path forward is the best course to achieve your goals.
Analysis Discovery
We gather financial and operational information to analyze trends, growth opportunities, and the metrics that drive platform multiples.
Partner Selection Execution
We explore the qualitative factors that determine whether a potential partner aligns with your operating model and your doctors’ expectations.
Negotiation Execution
We procure multiple offers, create a true apples-to-apples comparison, and ensure maximum value by focusing on terms that matter most.
Letter of Intent Execution
We facilitate the LOI process so you enter into a well-structured agreement that accurately reflects the negotiated deal terms.
Due Diligence Close
Our team helps you navigate due diligence, ensuring the right partner fit and a smooth, timely path to closing.
Legal Review Close
We partner with your legal representatives to memorialize deal terms and help you understand all aspects of the legal documents.
Close Close
The best part: you’ve found the right partner, terms are agreed, contracts finalized, and funds received. Time to celebrate.
Life After Close Close
Our team supports you as you and your leadership team move into what comes next, answering questions and providing guidance along the way.
Frequently Asked Questions
No, and that is the better time. The decisions that determine your outcome are made years ahead of a transaction: how you structure doctor agreements, how much leverage you carry, whether your governance is consistent across the platform. Your exit strategy is not something you decide at the end. It is something you build every day through decisions about culture, leadership, and how the organization runs.
Possibly, but it is not the likeliest outcome. Private equity generally invests in businesses that have already reached meaningful scale with sophisticated infrastructure. Most emerging DSOs partner with or are acquired by another DSO instead. If attracting institutional capital directly is the goal, your organization has to look different from the average emerging platform, and that has implications for how you build today.
Less than founders expect comes from supported location count. Buyers look at same-store sales growth, provider retention and recruiting, margin consistency across locations, the quality of your management team, and how much of the business depends on you personally. We model where you stand on each of these and what moves the number before you go to market.
Sometimes, but do not assume it. Some strategic partners retain the existing leadership team and some already have one. This is a term to negotiate deliberately rather than discover late, and it affects deal structure, your equity treatment, and what you should be building into the organization now so that it runs without you.
Carefully, and earlier than most leaders think. Your doctors are stakeholders in the outcome and their expectations were set by whatever they were told when they signed. Managing that communication is one of the hardest parts of a platform transition, and the part former DSO CEOs most often say they would handle differently. We help you plan the sequence and the message before anything becomes public.
Nearly everything is different. There are more stakeholders, financial diligence goes deeper, the legal work is heavier, quality of earnings becomes central, and equity rollover and governance terms carry more weight than headline price. There are also fewer credible buyers, which means competitive tension has to be created deliberately. Going without someone in the middle to negotiate is what breaks a meaningful number of these deals.